TrialJournal of cancer research and clinical oncology2017

Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.

Mao Lin et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.